Stina M. Oredsson

Lund, M 22362, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Corrigendum to "Preparation of a universally usable, animal product free, defined medium for 2D and 3D culturing of normal and cancer cells" [MethodsX 12 (2024) 102592].

Corrigendum to "Preparation of a universally usable, animal product free, defined medium for 2D and 3D culturing of normal and cancer cells" [MethodsX 12 (2024) 102592].

Journal: MethodsX

Published: January 06, 2026

Revisiting 3Rs: rethinking replacement and new approach methodologies.

Revisiting 3Rs: rethinking replacement and new approach methodologies.

Journal: Frontiers in toxicology

Published: July 11, 2025

Fetal bovine serum: how to leave it behind in the pursuit of more reliable science.

Fetal bovine serum: how to leave it behind in the pursuit of more reliable science.

Journal: Frontiers in toxicology

Published: April 16, 2025

Animal product-free formation and cultivation of three-dimensional primary hepatocyte spheroids.

Animal product-free formation and cultivation of three-dimensional primary hepatocyte spheroids.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: January 21, 2025

Ropivacaine and lidocaine at clinically relevant concentrations suppress proliferation and migration of ovarian cancer cells and induce morphological alterations.

Ropivacaine and lidocaine at clinically relevant concentrations suppress proliferation and migration of ovarian cancer cells and induce morphological alterations.

Journal: Advances in medical sciences

Published: January 11, 2025

Protocol for the use of Oredsson universal replacement medium for cell banking and routine culturing of monolayer and suspension cultures.

Protocol for the use of Oredsson universal replacement medium for cell banking and routine culturing of monolayer and suspension cultures.

Journal: STAR protocols

Published: December 04, 2024

Editorial: Five grand challenges in toxicology.

Editorial: Five grand challenges in toxicology.

Journal: Frontiers in toxicology

Published: November 23, 2024

Advancing humanized 3D tumor modeling using an open access xeno-free medium.

Advancing humanized 3D tumor modeling using an open access xeno-free medium.

Journal: Frontiers in toxicology

Published: November 16, 2024

High-throughput non-homogenous 3D polycaprolactone scaffold for cancer cell and cancer-associated fibroblast mini-tumors to evaluate drug treatment response.

High-throughput non-homogenous 3D polycaprolactone scaffold for cancer cell and cancer-associated fibroblast mini-tumors to evaluate drug treatment response.

Journal: Toxicology reports

Published: October 01, 2024

Preparation of a universally usable, animal product free, defined medium for 2D and 3D culturing of normal and cancer cells.

Preparation of a universally usable, animal product free, defined medium for 2D and 3D culturing of normal and cancer cells.

Journal: MethodsX

Published: December 04, 2023

A new animal product free defined medium for 2D and 3D culturing of normal and cancer cells to study cell proliferation and migration as well as dose response to chemical treatment.

A new animal product free defined medium for 2D and 3D culturing of normal and cancer cells to study cell proliferation and migration as well as dose response to chemical treatment.

Journal: Toxicology reports

Published: November 15, 2022

Case Studies Exemplifying the Transition to Animal Component-free Cell Culture.

Case Studies Exemplifying the Transition to Animal Component-free Cell Culture.

Journal: Alternatives to laboratory animals : ATLA

Published: August 19, 2022

Showing 1-12 of 53

Last Updated: 09/26/2026